Search results for: 'c-Abl'
-
K1046 RNase Inhibitor, MurineSummary: RNase Inhibitor, Murine specifically inhibits RNases A, B and C to protect RNA from degradation. -
R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)Summary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1020 EZ Cap™ EPO mRNA (ψUTP)Summary: Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
-
K1109 Thermolabile UDG (Uracil DNA glycosylase)Summary: Uracil-DNA glycosylase (Heat-labile) for the elimination of product contamination in PCR
-
R1001 ARCA EGFP mRNASummary: Direct-detection reporter mRNA, used as control to study transfection and expression in mammalian cells.
-
R1007 ARCA EGFP mRNA (5-moUTP)Summary: New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
-
R1005 Firefly Luciferase mRNA (ARCA, 5mCTP, ψUTP)Summary: Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
-
R1012 Firefly Luciferase mRNA (ARCA, 5-moUTP)Summary: Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
-
R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)Summary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1015 EZ Cap™ Cas9 mRNA (5-moUTP)Summary: Used with guideRNA for site-specific DNA cleavage in genome editing.